515 related articles for article (PubMed ID: 25938545)
61. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
[TBL] [Abstract][Full Text] [Related]
62. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
63. Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells.
Qin Y; Zhang Q; Lee S; Zhong WL; Liu YR; Liu HJ; Zhao D; Chen S; Xiao T; Meng J; Jing XS; Wang J; Sun B; Dai TT; Yang C; Sun T; Zhou HG
Oncotarget; 2015 Dec; 6(38):40667-79. PubMed ID: 26512779
[TBL] [Abstract][Full Text] [Related]
64. Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer.
Kang J; Kang YH; Oh BM; Uhm TG; Park SY; Kim TW; Han SR; Lee SJ; Lee Y; Lee HG
Tumour Biol; 2016 Oct; 37(10):13843-13853. PubMed ID: 27485112
[TBL] [Abstract][Full Text] [Related]
65. Rab40b upregulation correlates with the prognosis of gastric cancer by promoting migration, invasion, and metastasis.
Li Y; Jia Q; Wang Y; Li F; Jia Z; Wan Y
Med Oncol; 2015 Apr; 32(4):126. PubMed ID: 25790780
[TBL] [Abstract][Full Text] [Related]
66. Lentivirus-mediated shRNA interference targeting SLUG inhibits lung cancer growth and metastasis.
Wang YP; Wang MZ; Luo YR; Shen Y; Wei ZX
Asian Pac J Cancer Prev; 2012; 13(10):4947-51. PubMed ID: 23244088
[TBL] [Abstract][Full Text] [Related]
67. Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Wu Y; Wang H; Qiao L; Jin X; Dong H; Wang Y
Thorac Cancer; 2019 Sep; 10(9):1748-1763. PubMed ID: 31317661
[TBL] [Abstract][Full Text] [Related]
68. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
[TBL] [Abstract][Full Text] [Related]
69. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
70. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
71. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
72. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
73. AEG-1 activates Wnt/PCP signaling to promote metastasis in tongue squamous cell carcinoma.
Pan Y; Guo X; Yang Z; Chen S; Lei Y; Lin M; Wang L; Feng C; Ke Z
Oncotarget; 2016 Jan; 7(2):2093-104. PubMed ID: 26689985
[TBL] [Abstract][Full Text] [Related]
74. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O
Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681
[TBL] [Abstract][Full Text] [Related]
75. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
[TBL] [Abstract][Full Text] [Related]
76. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
Chen D; Cao G; Liu Q
J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
[TBL] [Abstract][Full Text] [Related]
77. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
78. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
[TBL] [Abstract][Full Text] [Related]
79. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
80. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.
Liu Z; Mai C; Yang H; Zhen Y; Yu X; Hua S; Wu Q; Jiang Q; Zhang Y; Song X; Fang W
J Cell Mol Med; 2014 Aug; 18(8):1667-79. PubMed ID: 24976536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
